| Determination of metanephrines in plasma by liquid chromatography with electrochemical detection JW Lenders, G Eisenhofer, I Armando, HR Keiser, DS Goldstein, IJ Kopin Clinical chemistry 39 (1), 97-103, 1993 | 237 | 1993 |
| Peripheral Administration of an Angiotensin II AT1 Receptor Antagonist Decreases the Hypothalamic-Pituitary-Adrenal Response to Isolation Stress I Armando, A Carranza, Y Nishimura, KL Hoe, M Barontini, JA Terrón, ... Endocrinology 142 (9), 3880-3889, 2001 | 187 | 2001 |
| Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury C Bregonzio, I Armando, H Ando, M Jezova, G Baiardi, JM Saavedra American Journal of Physiology-Gastrointestinal and Liver Physiology 285 (2 …, 2003 | 183 | 2003 |
| Estrogen upregulates renal angiotensin II AT2receptors I Armando, M Jezova, AV Juorio, JA Terrón, A Falcón-Neri, ... American Journal of Physiology-Renal Physiology 283 (5), F934-F943, 2002 | 169 | 2002 |
| Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists JM Saavedra, H Ando, I Armando, G Baiardi, C Bregonzio, A Juorio, ... Regulatory peptides 128 (3), 227-238, 2005 | 163 | 2005 |
| Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat G Baiardi, M Macova, I Armando, H Ando, D Tyurmin, JM Saavedra Regulatory peptides 124 (1-3), 7-17, 2005 | 131 | 2005 |
| Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene OA Tjurmina, I Armando, JM Saavedra, DS Goldstein, DL Murphy Endocrinology 143 (12), 4520-4526, 2002 | 130 | 2002 |
| Dopamine and renal function and blood pressure regulation I Armando, MV Van Anthony, PA Jose Comprehensive Physiology 1 (3), 1075, 2011 | 129 | 2011 |
| Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study K Pacak, I Armando, K Fukuhara, R Kvetnatsky, M Palkovits, IJ Kopin, ... Brain research 589 (1), 91-96, 1992 | 125 | 1992 |
| A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding JM Saavedra, I Armando, C Bregonzio, A Juorio, M Macova, J Pavel, ... Neuropsychopharmacology 31 (6), 1123-1134, 2006 | 124 | 2006 |
| Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F] fluorodopamine: initial findings in humans DS Goldstein, G Eisenhofer, BB Dunn, I Armando, J Lenders, E Grossman, ... Journal of the American College of Cardiology 22 (7), 1961-1971, 1993 | 114 | 1993 |
| Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice C Zeng, I Armando, Y Luo, GM Eisner, RA Felder, PA Jose American Journal of Physiology-Heart and Circulatory Physiology 294 (2 …, 2008 | 113 | 2008 |
| The regulation of proximal tubular salt transport in hypertension: an update X Wang, I Armando, K Upadhyay, A Pascua, PA Jose Current opinion in nephrology and hypertension 18 (5), 412-420, 2009 | 104 | 2009 |
| Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress I Armando, S Volpi, G Aguilera, JM Saavedra Brain research 1142, 92-99, 2007 | 103 | 2007 |
| Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities JM SAAVEDRA, H Ando, I Armando, G Baiardi, C Bregonzio, M Jezova, ... Annals of the New York Academy of Sciences 1018 (1), 76-84, 2004 | 100 | 2004 |
| Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells H Li, I Armando, P Yu, C Escano, SC Mueller, L Asico, A Pascua, Q Lu, ... The Journal of clinical investigation 118 (6), 2180-2189, 2008 | 99 | 2008 |
| Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT1A, AT1B and AT2 receptors DS Leong, JA Terrón, A Falcón-Neri, I Armando, T Ito, O Jöhren, ... Neuroendocrinology 75 (4), 227-240, 2002 | 99 | 2002 |
| Renal dopamine receptors, oxidative stress, and hypertension S Cuevas, VA Villar, PA Jose, I Armando International journal of molecular sciences 14 (9), 17553-17572, 2013 | 97 | 2013 |
| Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats A Seltzer, C Bregonzio, I Armando, G Baiardi, JM Saavedra Brain research 1028 (1), 9-18, 2004 | 93 | 2004 |
| Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production S Cuevas, Y Zhang, Y Yang, C Escano, L Asico, JE Jones, I Armando, ... Hypertension 59 (2), 446-452, 2012 | 87 | 2012 |
Van Anthony M. VillarGeorge Washington University在 gwu.edu 的电子邮件经过验证
